The role Time in range depending on the method of assessing glycemic control in diabetes: A review

Cover Page

Cite item

Full Text

Abstract

Despite modern advances in diabetology, diabetes is a progressive non-communicable disease with the possible development of vascular complications, which is a global health problem. Therefore, maintaining optimal glycemic control is important for managing diabetes and preventing the development of acute and chronic complications of the disease. One of the parameters for assessing glycemic control is the indicator of time in the target range (Time in range – TIR), calculated on the basis of data from continuous glucose monitoring (CGM), which is quite simple and convenient to calculate and use, and also has a proven connection with the development of micro- and macrovascular complications of diabetes. However, the main obstacle to the widespread use of TIR is the limited use of CGM systems. Therefore, of particular interest is the study of the derived indicator of the time in range of glycemia (derived TIR – dTIR), obtained on the basis of self-monitoring of blood glucose. In this review, the issues of the relationship of TIR, dTIR with HbA1c levels, the development of micro- and macrovascular complications of diabetes type 1 and 2 are discussed, and the comparability of TIR and dTIR is analyzed.

About the authors

Lyudmila A. Suplotova

Tyumen State Medical University

Author for correspondence.
Email: suplotovala@mail.ru
ORCID iD: 0000-0001-9253-8075
SPIN-code: 1212-5397

D. Sci. (Med.), Prof.

Russian Federation, Tyumen

Anna S. Sudnitsyna

Regional Clinical Hospital №1

Email: dr.sudnitsyna@mail.ru
ORCID iD: 0000-0002-1932-1686
SPIN-code: 2347-6680

endocrinologist

Russian Federation, Tyumen

Tatyana S. Dushina

Tyumen State Medical University

Email: dr.dushina@mail.ru
ORCID iD: 0000-0002-6329-593X

Аssistant

Russian Federation, Tyumen

References


Copyright (c) 2022 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies